Ryman Healthcare Limited (NZE:RYM)
2.160
-0.040 (-1.82%)
Jul 9, 2026, 4:59 PM NZST
Ryman Healthcare Ratios and Metrics
Market cap in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 8, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,191 | 2,151 | 2,799 | 3,117 | 3,598 | 4,665 | |
Market Cap Growth | -1.82% | -23.14% | -10.22% | -13.35% | -22.88% | -38.69% |
Enterprise Value | 3,770 | 3,838 | 5,409 | 5,605 | 6,623 | 7,122 |
Last Close Price | 2.16 | 2.12 | 2.76 | 4.21 | 4.86 | 7.96 |
PE Ratio | - | - | - | - | 13.95 | 6.73 |
Forward PE | 18.51 | 14.26 | 12.14 | 11.17 | 10.18 | 16.49 |
PS Ratio | 2.56 | 2.52 | 3.69 | 4.53 | 6.19 | 9.17 |
PB Ratio | 0.54 | 0.53 | 0.67 | 0.83 | 0.77 | 1.36 |
P/TBV Ratio | 0.54 | 0.53 | 0.67 | 0.84 | 0.79 | 1.38 |
P/FCF Ratio | 7.77 | 7.63 | 10.28 | 7.92 | 16.43 | 18.54 |
P/OCF Ratio | 6.56 | 6.44 | 6.82 | 5.24 | 5.61 | 7.96 |
PEG Ratio | - | - | - | - | - | 6.97 |
EV/Sales Ratio | 4.41 | 4.49 | 7.13 | 8.15 | 11.39 | 14.00 |
EV/EBITDA Ratio | 46.67 | 49.26 | 1290.06 | - | 272.11 | 205.02 |
EV/EBIT Ratio | 98.62 | 100.42 | - | - | 3810.78 | 1044.34 |
EV/FCF Ratio | 13.37 | 13.62 | 19.86 | 14.25 | 30.24 | 28.30 |
Debt / Equity Ratio | 0.39 | 0.39 | 0.41 | 0.69 | 0.50 | 0.76 |
Debt / EBITDA Ratio | 19.79 | 19.79 | 211.94 | - | 84.83 | 69.96 |
Debt / FCF Ratio | 5.67 | 5.67 | 6.28 | 6.56 | 10.73 | 10.40 |
Net Debt / Equity Ratio | 0.39 | 0.39 | 0.40 | 0.67 | 0.49 | 0.75 |
Net Debt / EBITDA Ratio | 20.26 | 20.26 | 403.43 | -65.11 | 93.94 | 73.97 |
Net Debt / FCF Ratio | 5.60 | 5.60 | 6.21 | 6.41 | 10.44 | 10.21 |
Asset Turnover | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | 0.05 |
Inventory Turnover | 61895.52 | 61895.52 | 626.17 | 83.74 | 26.49 | 17.58 |
Quick Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.14 | 0.69 |
Current Ratio | 0.04 | 0.04 | 0.04 | 0.06 | 0.15 | 0.73 |
Return on Equity (ROE) | -4.15% | -4.15% | -12.96% | -4.04% | 6.37% | 22.12% |
Return on Assets (ROA) | 0.20% | 0.20% | -0.21% | -0.36% | 0.01% | 0.04% |
Return on Invested Capital (ROIC) | 0.68% | 0.66% | -0.66% | -1.06% | 0.03% | 0.12% |
Return on Capital Employed (ROCE) | 0.60% | 0.60% | -0.70% | -1.10% | 0.00% | 0.10% |
Earnings Yield | -7.82% | -7.96% | -18.36% | -5.44% | 7.17% | 14.85% |
FCF Yield | 12.86% | 13.10% | 9.73% | 12.62% | 6.09% | 5.39% |
Dividend Yield | - | - | - | - | 1.81% | 2.81% |
Payout Ratio | - | - | - | - | 26.41% | 16.16% |
Buyback Yield / Dilution | -43.02% | -43.02% | -3.28% | -33.18% | -3.26% | - |
Total Shareholder Return | -43.02% | -43.02% | -3.28% | -33.18% | -1.45% | 2.81% |